According to the Zhitong Finance App, Shenwei Pharmaceutical (02877) announced that the profit attributable to company owners for the year ending December 31, 2023 is expected to increase by about 30% to 36% over the same period last year (2022: about RMB 723 million).
The expected increase in profit attributable to company owners this year is mainly due to an increase in the Group's overall sales revenue of about 14% compared to last year and a decrease of about 2 to 3 percent in the ratio of sales and distribution costs to turnover compared to last year.